Table 1.
ArKO | αERKO | βERKO | αβERKO | NOER | MOER | |
---|---|---|---|---|---|---|
Fertility | Initially fertile although with advancing age they developed progressive infertility. | Infertile | Fertile/Infertile* | Infertile | Initially subfertile, becoming infertile with advancing age | Infertile |
Gonadotropins | ||||||
Serum LH | Elevated | Not significantly higher | NA | NA | Normal | NA |
Serum FSH | Normal | Not significantly higher | NA | NA | Normal | NA |
Serum Steroids | ||||||
Androgens | Tendency toward elevated levels | Elevated | NA | NA | Elevated | NA |
Estrogens | Normal | NA | NA | Normal | NA | |
Testicular function | At ~12–14 weeks of age the internal anatomy of the male ArKO mice showed increased weight because of the seminal vesicles (caused by increased volume of secretions) and combined urinary bladder/prostate but no difference in the testes weight. Leydig cell hyperplasia/hypertrophy |
Testis weight significantly reduced. Disruption of seminiferous tubules. |
Normal with some age-related abnormalities in the prostate and bladder | Showed similar phenotype as male αERKO mice. | At 4 months of age seminiferous tubular degeneration. At 8 months of age: significant histological alterations in testis, rete testis, and efferent ductus. |
NA |
Sperm | Disruptions in spermatogenesis with increased frequency of germ cell apoptosis and defects in spermiogenesis with the epididymis showing reduced or complete absence of sperm | In adulthood quantity and quality of sperm affected. Spermatogenic stem cells not affected |
Normal | Similar to male αERKO mice | Decreased sperm production with impaired sperm motility and viability | NA |
AnERβ mouse mutant generated by Cre/LoxP deletion of exon 3; reported impaired mating, suggesting male infertility (46).
NA, Not Available.